UPDATE : Friday, July 10, 2020
상단여백
‘Parasiticide showed antiviral effect as potential Covid-19 drug’ by Jeong Sae-im 2020-04-24 12:27
French envoy visits Pasteur Korea to watch Covid-19 research by Jeong Sae-im 2020-04-23 17:13
4 drugs recorded two-digit sales growth in Q1 despite Covid-19 by Jeong Sae-im 2020-04-23 12:18
Medytox’s faking data unpunishable due to expired statute of limitations by Jeong Sae-im 2020-04-22 11:28
Whistleblowers, shareholders furious over Medytox’s rebuttal by Jeong Sae-im 2020-04-21 15:19
라인
ImmuneMed confident of drug candidate’s effect on Covid-19 by Jeong Sae-im 2020-04-21 13:23
‘Stem cell therapy more effective on Covid-19’ by Jeong Sae-im 2020-04-21 11:01
Osang Healthcare wins US nod for Covid-19 test kit by Jeong Sae-im 2020-04-20 11:58
‘Natural Killer cells predict immunotherapy’s efficacy in lung cancer patients’ by Jeong Sae-im 2020-04-17 16:07
Medytox CEO charged with making, selling botulinum toxin illegally by Jeong Sae-im 2020-04-17 16:00
라인
Bukwang to test its antiviral drug against Covid-19 by Jeong Sae-im 2020-04-16 12:20
What are the odds for successful Invossa trials in US? by Jeong Sae-im 2020-04-14 15:01
FDA OKs resumption of phase-3 Invossa trial in US by Jeong Sae-im 2020-04-13 11:58
Korean diagnostics industry to enjoy unprecedented boom by Jeong Sae-im 2020-04-09 14:30
Executive salaries highest at Samsung Biologics, Celltrion by Jeong Sae-im 2020-04-09 11:13
라인
No Korean firms have entered trials to test COVID-19 drug candidates by Jeong Sae-im 2020-04-08 16:15
3 drug candidates authorized to treat COVID-19 patients by Jeong Sae-im 2020-04-07 15:50
COVID-19 plasma therapy hits snag due to blood supply regulation by Jeong Sae-im 2020-04-06 15:22
ImmuneMed under fire for inflating drug’s effect against COVID-19 by Jeong Sae-im 2020-03-27 11:49
Has Moon promised beyond Korean equipment makers’ capacity? by Jeong Sae-im 2020-03-26 14:56
여백
여백
여백
Back to Top